We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/4/2012 10:37 | Surely the FSA can launch an investigation in who was selling or shorting this stock before the placing? How many more times do we have to see companies, puzzlingly, mysteriously, suddenly sold off aggresively before a placing. Then the placing occurs and it shoots back up as the 'smart' money goes back in. | shuisky | |
08/2/2012 19:58 | Interim 21 Feb. Strong steady share price movement. Any views? apad | apad | |
13/1/2012 07:43 | Questor:Dechra Pharmaceuticals Telegraph | 13-Jan-2012 | intouch | |
07/11/2011 16:38 | Tipped in press | nellie1973 | |
04/11/2011 21:48 | Well the IMS is impressive! Looking very good across the board. Big jump in Sp to reflect this. May now push-on to 600. | audigger | |
03/11/2011 16:07 | Should get an Interim Management Statement tomorrow along with the AGM. Did last year... I'm hopeful for good progress on the US pharma side of the business (high margin).. not so confident on the UK services division. | 1356 | |
12/9/2011 07:34 | Why the reason for the rise? Has this been tipped somewhere? | shuisky | |
10/9/2011 09:31 | Held up well considering the general state of the market both here and across the pond! | moneyfinger3 | |
09/9/2011 12:15 | Flying now. Could break to a new high! | audigger | |
08/9/2011 15:10 | 500 looking entriely possible! | audigger | |
06/9/2011 06:49 | Results are ok. NVS margins are under pressure due to consolidation in the industry, a weak UK market and online competition. Moreover, it appears that this consolidation is creating greater WC requirements because larger customers are better placed to demand better payment terms from NVS. European Pharma margins slipping too and given that this is 55.6% of segmental profit, this is a concern. | shuisky | |
06/9/2011 06:04 | Should see some momentum north based on these results despite the market being hammered | audigger | |
02/9/2011 12:48 | I wonder what the results may bring next week? Is the US growth story continues then we may see a move back towards 500. | audigger | |
14/7/2011 16:29 | I think this is a strong defensive play, but with a hidden bit of growth that not everyone fully appreciates... The revenue growth in the US, is all high margin, and I think this will do very well in the years ahead... dyor, etc. | 1356 | |
13/7/2011 09:12 | GJ Quite right. Blonde moment. Ta. apad | apad | |
12/7/2011 21:30 | Hi APAD : Assuming you are commenting on Monday's Trading Update, I cannot find any reference to profit in the statement ? | gj2 | |
12/7/2011 08:01 | US sales up 50% overall profits up 5%. says costs to me not expecting much here. apad | apad | |
11/7/2011 16:51 | A wock solid statement | cheiftown |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions